Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEPSYM: Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae in Sepsis
NCT07746050Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Montreal Cognitive Assessment at 3 months. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07746050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746050.